EGFR and lung carcinoma: These findings are helpful to further understand the molecular mechanisms of arsenic-induced carcinogenesis and angiogenesis, and the miR-218-5p/EGFR signaling pathway may be a potential therapeutic target for the treatment of lung cancer induced by chronic arsenic exposure in the future.